Your browser doesn't support javascript.
loading
Updated clinical and biological information from the two-stage phase II study of imatinib mesylate in subjects with relapsed/refractory neuroblastoma.
Morandi, Fabio; Amoroso, Loredana; Dondero, Alessandra; Castriconi, Roberta; Parodi, Stefano; Luksch, Roberto; Casale, Fiorina; Castellano, Aurora; Garaventa, Alberto; Moretta, Alessandro; Bottino, Cristina; Ponzoni, Mirco; Corrias, Maria Valeria.
Affiliation
  • Morandi F; Experimental Therapy in Oncology, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
  • Amoroso L; Pediatric Oncology, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
  • Dondero A; Dipartimento di Medicina Sperimentale, Università degli Studi di Genova, Genoa, Italy.
  • Castriconi R; Dipartimento di Medicina Sperimentale, Università degli Studi di Genova, Genoa, Italy.
  • Parodi S; Centre of Excellence for Biomedical Research, Università degli Studi di Genova, Genoa, Italy.
  • Luksch R; Epidemiology and Biostatistics Section, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
  • Casale F; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Castellano A; Università della Campania "L.Vanvitelli", Napoli, Italy.
  • Garaventa A; Department of Hematology-Oncology, IRCCS Ospedale Bambino Gesù, Rome, Italy.
  • Moretta A; Pediatric Oncology, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
  • Bottino C; Dipartimento di Medicina Sperimentale, Università degli Studi di Genova, Genoa, Italy.
  • Ponzoni M; Centre of Excellence for Biomedical Research, Università degli Studi di Genova, Genoa, Italy.
  • Corrias MV; Dipartimento di Medicina Sperimentale, Università degli Studi di Genova, Genoa, Italy.
Oncoimmunology ; 7(9): e1468953, 2018.
Article in En | MEDLINE | ID: mdl-30357053

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Oncoimmunology Year: 2018 Document type: Article Affiliation country: Italy

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Oncoimmunology Year: 2018 Document type: Article Affiliation country: Italy